Global Next generation cancer diagnostics Market Analysis, Segmentation, Competitors Analysis, Product Research, Trends and Forecast by 2022

According to Stratistics MRC, the Global Next Generation Cancer Diagnostics market is estimated at $2.95 billion in 2015 and is expected to grow at a CAGR of 32.6% to reach $20.93 billion by 2022. Growing incidence of oncology diseases is expected to boost the demand for next generation cancer diagnostic tests market. However, lack of sufficient reimbursement policies for novel technologies and stringent regulatory procedures are the major factors that can hamper the global next generation cancer diagnostics market growth over the forecast period.

Browse the report: http://www.orbisresearch.com/reports/index/next-generation-cancer-diagnostics-global-market-outlook-2015-2022

The largest segment of the global market for next generation cancer diagnostics is Blood-born cancers. Asia Pacific is likely to be one of the fastest growing regions of this sector and is anticipated to grow at a lucrative rate. A largely untouched market base which has exhibited technological advancements in healthcare research during the past decade is responsible for rapid growth in this region.

Some of the key players in the global Next Generation Cancer Diagnostics market are Thermo Fisher Scientific, Inc., Roche, Philips Electronics NV, Perkin Elmer Inc., Novartis AG, Lab-on-a-chip, Illumina, Inc., Agilent Technologies Inc, Siemens Healthcare, Johnson & Johnson, Hologic Inc., GE Healthcare, C.R. Bard, Inc and Abbot.

Request a sample of the report: http://www.orbisresearch.com/contacts/request-sample/184643

Cancer Type Covered:
Lung Cancer
Colorectal Cancer
Cervical Cancer
Breast Cancer
Other Cancer Types

Functions Covered:
Therapeutic Monitoring
Risk analysis
Prognostics diagnosis
Companion Diagnostics
Cancer Screening

Technologies Covered:
Platform-Based Diagnostics
Polymerase Chain Reaction (PCR)
Next-Generation Sequencing (NGS)
Microarrays
In Situ Hybridization (ISH)
Immunohistochemistry (IHC)
Flow Cytometry
Other Technologies
Instrument-Based
Diagnostic Imaging
Ultrasound
Mammography
Biopsies

Regions Covered:
North America
US
Canada
Mexico
Europe
Germany
France
Italy
UK
Spain
Rest of Europe
Asia Pacific
Japan
China
India
Australia
New Zealand
Rest of Asia Pacific
Rest of the World
Middle East
Brazil
Argentina
South Africa
Egypt

What our report offers:
– Market share assessments for the regional and country level segments
– Market share analysis of the top industry players
– Strategic recommendations for the new entrants
– Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
– Strategic recommendations in key business segments based on the market estimations
– Competitive landscaping mapping the key common trends
– Company profiling with detailed strategies, financials, and recent developments
– Supply chain trends mapping the latest technological advancements

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Information:

Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Email: sales@orbisresearch.com

Global Companion Diagnostics Market Projections, SWOT Analysis, Risk Analysis, Trends and Forecast by 2022

According to Stratistics MRC, the Global Companion Diagnostics Market is accounted for $2.62 billion in 2015 and is expected to reach $9.27 billion by 2022 growing at a CAGR of 19.78% during the forecast period. At present, increasing demand for personalized medicine is mostly contributing to the global companion diagnostics market growth. On the other hand, cost allied with developing drugs could hamper the market. Developing companion diagnostics for several central nervous system conditions and hereditary conditions provide ample of opportunities for players in the market.

Browse the report: http://www.orbisresearch.com/reports/index/companion-diagnostics-global-market-outlook-2015-2022

In terms of revenue, Breast cancer commanded the global companion diagnostics market. However, lung cancer is expected to lead the market in future growing at a significant CAGR owing to the discovery of biomarkers that are precise to lung cancer, and the discovery of myriad pertinent companion diagnostics. Molecular diagnostics is highest revenue generating segment and also expected to grow at a faster rate, mainly owing to the use of techniques such as real time PCR, In Situ Hybridization and next generation sequencing.

North America represented the largest market for companion diagnostics, followed by the Europe. The Asia Pacific and Rest of the World regions are anticipated to witness substantial demand for companion diagnostics in the future. In these regions, enhancing healthcare infrastructure, rising disposable incomes, and unexploited potential for companion diagnostics are cited as the major reasons for the market growth.

Request a sample of the report: http://www.orbisresearch.com/contacts/request-sample/184640

Some of the key players in the market include are Roche Diagnostics, Quest Diagnostics Inc.Qiagen N.V., Labcorp, Genomic Health Inc., Dako (Agilent Technologies), Celera, Biomerieux Sa, Abbott Laboratories, Thermo Fisher Scientific, Inc., Danaher Corporation, GE Healthcare, Biogenex Laboratories, Siemens and AstraZeneca.

Technologies Covered:
Molecular diagnostics
In Situ Hybridization (ISH)
CISH
FISH
Polymerase Chain Reaction (PCR)
Next generation sequencing
Other Technologies
Immunohistochemistry

Applications Covered:
Colorectal Cancer
Gastric Cancer
Lung Cancer
Breast Cancer
Melanoma
Other Applications
Indications Covered:
Cardiovascular conditions
Inflammation
Virology
Oncology
Other Indications

End User’s Covered:
Pharmaceutical Companies
Reference Lab
Physicians
Hospitals
Academic Medical Centers

Regions Covered:
North America
US
Canada
Mexico
Europe
Germany
France
Italy
UK
Spain
Rest of Europe
Asia Pacific
Japan
China
India
Australia
New Zealand
Rest of Asia Pacific
Rest of the World
Middle East
Brazil
Argentina
South Africa
Egypt

What our report offers:
– Market share assessments for the regional and country level segments
– Market share analysis of the top industry players
– Strategic recommendations for the new entrants
– Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
– Strategic recommendations in key business segments based on the market estimations
– Competitive landscaping mapping the key common trends
– Company profiling with detailed strategies, financials, and recent developments
– Supply chain trends mapping the latest technological advancements

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Information:

Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Email: sales@orbisresearch.com

Global Autoimmune Disease Therapeutics Market is Expected to Reach $82.13 billion by 2022

According to Stratistics MRC, the Global Autoimmune Disease Therapeutics Market is accounted for $51.2 billion in 2015 and is expected to reach $82.13 billion by 2022 growing at a CAGR of 6.9% during the forecast period. Rising healthcare expenditure in the region is one of the key factors fueling the market growth. On the other hand, insufficient funding in emerging countries and high cost involved in the treatment of the disease are hindering the market. Biologics drug acts as initial line of treatment due to therapeutic capabilities in controlling and treatment of different autoimmune complications.

Browse the report: http://www.orbisresearch.com/reports/index/autoimmune-disease-therapeutics-global-market-outlook-2015-2022

North America is the largest market for autoimmune disease therapeutics due to increasing incidence of different forms of autoimmune disorders, and government initiatives in the region. Europe is expected to be the second largest market due to rising healthcare infrastructure and penetration of new technologies.

Some of the key players in the market include Johnson & Johnson Inc, Bayer Schering Pharma AG, Elan Corporation Plc, Abbott Laboratories, Genentech Inc, GlaxoSmithKline Plc, Bristol-Myers Squibb, Chugai Pharmaceutical Co. Ltd., Merck & Co. Inc, Amgen Inc, Eli Lilly and Company, F. Hoffmann-La Roche AG, Biogen Idec Inc, Teva Pharmaceuticals, Industries Limited, UCB S.A., Sanofi-Aventis SA, Novartis AG and Shire Plc.

Request a sample of the report: http://www.orbisresearch.com/contacts/request-sample/184639

Distribution Channel:
Drug Stores
Hospitals
Independent Pharmacies
Clinics

Drug Class Covered:
Anti-Inflammatory Drugs
Biologics
Immunosuppressant’s
Nonsteroidal anti-inflammatory drugs
Corticosteroids

Regions Covered:
North America
US
Canada
Mexico
Europe
Germany
France
Italy
UK
Spain
Rest of Europe
Asia Pacific
Japan
China
India
Australia
New Zealand
Rest of Asia Pacific
Rest of the World
Middle East
Brazil
Argentina
South Africa
Egypt

What our report offers:
– Market share assessments for the regional and country level segments
– Market share analysis of the top industry players
– Strategic recommendations for the new entrants
– Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
– Strategic recommendations in key business segments based on the market estimations
– Competitive landscaping mapping the key common trends
– Company profiling with detailed strategies, financials, and recent developments
– Supply chain trends mapping the latest technological advancements

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Information:

Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Email: sales@orbisresearch.com

Continuous Peripheral Nerve Block Catheter Global Market Analysis, Share, Trends and Forecast by 2022

According to Stratistics MRC, the Global Continuous Peripheral Nerve Block Catheter Market is valued at $XX million in 2015 and is expected to reach $XX million by 2022 growing at a CAGR of XX% from 2015 to 2022. The rising demand for orthopedic surgeries is the primary factor fuelling the market growth. Furthermore, better pain control, fewer side effects, acceptance to advanced techniques, earlier home discharge for select subset of hospitalized patients, shorter hospitalization and increase in quality of life are some of the drivers favoring the market growth. However, high cost of product, the stringent regulation for approval of catheters by government agencies, catheter infections are restricting the market growth. The recent trend for Continuous Peripheral Nerve Block Catheter is improvement in management of pain grabbing which has gained more attention and is witnessing steady growth in the development of several catheters and techniques.

Browse the report: http://www.orbisresearch.com/reports/index/continuous-peripheral-nerve-block-catheter-global-market-outlook-2015-2022

Indication joint replacement segment commanded the largest market revenue in CPNB catheter market, owing to high prevalence in highly developed countries. North American region is expected to witness highest CAGR followed by Europe, and Asia-Pacific. Asia-Pacific countries are expected to adopt CPNB catheters owing to large aging population, increasing incidence of orthopedic surgeries, and increasing income of population.
Some of the key players in the market include BBraun Medical, Inc., Teleflex Incorporated, Halyard Health, Inc., InfuSystem, Stryker Corporation, Pajunk GmbH, Gamida, Te.Me.Na, Hotspur Technologies, Inc., Cohera Medical, Inc., Kimberly-Clark Corporation, Dyna Medical Corp, NPI Medical, Teva Pharmaceutical Industries Ltd. and Cephalon, Inc.

Request a sample of the report: http://www.orbisresearch.com/contacts/request-sample/184636

Products Covered:
Non-Stimulating catheters
Stimulating catheter

Insertion techniques Covered:
Tunneling
Nerve stimulation
Ultrasound

Indications Covered:
Trauma
Ambulatory Surgery
Upper extremity
Lower extremity
Thoracic, abdominal, pelvic, and urological surgery
Joint replacement

End Users Covered:
Ambulatory surgical centers
Hospitals

Regions Covered:
North America
US
Canada
Mexico
Europe
Germany
France
Italy
UK
Spain
Rest of Europe
Asia Pacific
Japan
China
India
Australia
New Zealand
Rest of Asia Pacific
Rest of the World
Middle East
Brazil
Argentina
South Africa
Egypt

What our report offers:
– Market share assessments for the regional and country level segments
– Market share analysis of the top industry players
– Strategic recommendations for the new entrants
– Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
– Strategic recommendations in key business segments based on the market estimations
– Competitive landscaping mapping the key common trends
– Company profiling with detailed strategies, financials, and recent developments
– Supply chain trends mapping the latest technological advancements

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Information:

Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Email: sales@orbisresearch.com

Cryptococcosis Market : Competitive Landscape, Technological Breakthroughs & Industry Analysis – 2024

Global Cryptococcosis Market: Overview

This report on the global cryptococcosis market analyzes the current and future scenario of the global market. Cryptococcosis disease burden is rising due to increase in susceptible patient population such as HIV-infected patients, solid organ transplantation recipients, and other immunosuppressive hosts. In addition, the huge patient base in Sub-Saharan countries fuels the growth of the cryptococcosis market. For instance, According to CDC, it is estimated that around 1 million cryptococcal meningitis cases occurs globally. Also, it is also seen that cryptococcosis mortality burden is very high which results in around 625,000 deaths every year. In addition, rise in private and public funding for creating awareness, and favorable regulatory scenario for new product launch are boosting the growth of the global cryptococcosis market.

Obtain Report Details @ http://www.transparencymarketresearch.com/cryptococcosis-market.html

The cryptococcosis market report comprises an elaborate executive summary, which includes market snapshot that provides information about various segments. It also provides information and data analysis of the global market with respect to the segments based on treatment, distribution channel, and geography. A detailed qualitative analysis of drivers and restraints, and opportunities has been provided in the market overview section. Additionally, the section comprises clinical trial analysis and key industry event analysis to help understand the competitive landscape in the market. This section also provides market attractiveness analysis in terms of geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global cryptococcosis market.

Global Cryptococcosis Market: Scope of the Study

Based on treatment, the market is segmented into Amphotericin B, Flucytosine, Fluconazole, and other antifungals. Amphotericin B further segmented into Amphocin, Fungizone and other products. Flucytosine further segmented into Ancobon and other products. Fluconazole includes Diflucan and other products. In treatment type, Flucytosine was the largest segment of the global cryptococcosis market in terms of revenue in 2015, driven by its increasing adoption in U.S. The market segments have been analyzed based on cost-effectiveness of the drugs, prevalence of the diseases, and growing diagnosis rate of cryptococcosis across the globe. The market size and forecast for each of these segments have been provided for the period from 2014 to 2024, along with their respective CAGRs for the forecast period from 2016 to 2024, considering 2015 as the base year.

Based on distribution channel, the global cryptococcosis market is segmented as hospital pharmacies, retail pharmacies, drug store, and mail order pharmacies. Retail pharmacy was the largest segment of the global market in terms of revenue in 2015 and is expected to continue to dominate the market by 2024, which is attributed to the increasing contribution of long term medication required for cryptococcosis treatment. Online purchase of drugs has been highly popular in most of the developed economies such as the U.S. and Japan.

Geographically, the global cryptococcosis market has been categorized into five major regions and the key countries in the respective region: North America (U.S. and Canada), Europe (U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, Japan, China, Australia and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, GCC Countries, and Rest of Middle East & Africa).

Fill The Form To Gain Deeper Insights On This Market @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14984

Global Cryptococcosis Market: Competitive Landscape

The report also profiles major players in the global cryptococcosis market based on various attributes such as company overview, financial overview, product portfolio, business strategies, SWOT analysis, and recent developments. Major players profiled in this report include Bristol-Myers Squibb Company, Janssen Biotech, Inc. (Johnson & Johnson), Abbott Laboratories, Novartis AG, Pfizer, Inc., Valeant Pharmaceuticals, Inc., Glenmark Pharmaceuticals and Sigmapharm Laboratories LLC.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact us:

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY – 12207

United States

Tel: +1-518-618-1030

USA – Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website:  http://www.transparencymarketresearch.com/

 

Global Pharmaceutical Excipients Market Analysis, Segmentation, Competitors Analysis, Product Research, Trends and Forecast by 2022

According to Stratistics MRC, the Pharmaceutical Excipients Market is valued at $6.31 billion in 2015 and is projected to reach $10.24 billion by 2022 growing at a CAGR of 7.16% from 2015 to 2022. This market is mainly driven by the increasing demand for functional excipients from the pharmaceutical industry. Increasing demand of patent cliffs, growing demand of generics, and emergence of recent excipients are some of the key factors contributing the market growth. However, increasing quality compliance and regulatory requirements for excipient manufacturers are some of the restraints hampering the market growth. Also restricted number of the U.S. FDA approved manufacturing sites due to regulatory restrictions may also inhibit the market growth. Additionally, Adoption of modern science and reduced drug toxicity are the major challenges faced by the pharmaceutical Excipients Market.

Browse the report: http://www.orbisresearch.com/reports/index/pharmaceutical-excipients-global-market-outlook-2015-2022

North American market accounted for the largest market share over the forecast period followed by Europe, Asia-Pacific, and the Rest of the World. Developed geographies like North America and Europe are likely to grow at lower CAGRs when compared to the Asia Pacific market.

Some of the key players in the market include Associated British Foods Plc, Croda International Plc, Evonik Industries Ag, Roquette, Colorcon, Inc., Huntsman Corporation, Eastman Chemical Company, Archer Daniels Midland Company (Adm), Lubrizol Corporation, Fmc Corporation, Avantor Performance Materials, Inc., The Dow Chemical Company, Ashland, Inc., P&G and Basf Se.

Request a sample of the report: http://www.orbisresearch.com/contacts/request-sample/184635

Products Covered:
Inorganic Chemicals
Calcium Phosphates
Calcium Carbonate
Calcium Sulphate
Halites
Metallic Oxides
Organic Chemicals
Carbohydrates
Petrochemicals
Oleochemicals
Proteins

Functionality Covered:
Fillers & Diluents
Binders
Suspension & Viscosity Agents
Coatings
Flavoring Agents
Disintegrants
Colorants
Lubricants & Glidants
Preservatives

Route of Administrations Covered
Oral Excipients
Tablets
Capsules
Soft Gelatine Capsules
Liquids
Topical Excipients
Parenteral Excipients
Other Excipients

Regions Covered:
North America
US
Canada
Mexico
Europe
Germany
France
Italy
UK
Spain
Rest of Europe
Asia Pacific
Japan
China
India
Australia
New Zealand
Rest of Asia Pacific
Rest of the World
Middle East
Brazil
Argentina
South Africa
Egypt

What our report offers:
– Market share assessments for the regional and country level segments
– Market share analysis of the top industry players
– Strategic recommendations for the new entrants
– Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
– Strategic recommendations in key business segments based on the market estimations
– Competitive landscaping mapping the key common trends
– Company profiling with detailed strategies, financials, and recent developments
– Supply chain trends mapping the latest technological advancements

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Information:

Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Email: sales@orbisresearch.com

Global Circulating Tumor Cells Market Primary Research, Risk Analysis, Product Research, Trends and Forecast by 2022

According to Stratistics MRC, the Global Circulating Tumor Cells Market is accounted for $4.41 billion in 2015 and is expected to reach $17.96 billion by 2022 growing at a CAGR of 19.2 % from 2015 to 2022. The rising demand for high Benefit-Cost Ratio (BCR) associated with CTCs prognostic technology is the major factor boosting the market growth. Furthermore, advancements in biomedical imaging and bioengineering technology are some of the key factors driving the market. However, high cost associated with the diagnosing and reluctance among people towards adopting highly developed prognostic technologies inhibit the market growth. The recent trends in global Circulating Tumor Cells are strengthening distribution network of CTCs prognostic technologies in emerging economies and the technical advancement of CTCs-based customized medicines.

Browse the report: http://www.orbisresearch.com/reports/index/circulating-tumor-cells-global-market-outlook-2015-2022

Tumor cell detection is the foremost product segment primarily due to the advantages related with therapeutic monitoring and high procedure prices. North America region is expected to witness highest growth rate during the forecast period due to increasing demand in number of research projects. In addition, the U.S. Government also supports research by funding various institutes, which grant research funds.

Some of the key players in the market include Adnagen AG, Advanced Cell Diagnostics, Apocell, Aviva Biosciences, Biocep Ltd., Biocept Inc., Biofluidica, Canopus Biosciences, CellTraffix Inc., Clearbridge BioMedics, Creatv Microtech Inc., Cynvenio Biosystems Inc. , Epic Biosciences, Fluxion Biosciences., Greiner Bio-One GmbH, Ikonisys Inc., IV Diagnostics Inc., Janssen Diagnostics, Miltenyi Biotech and Nanostring Technologies Inc.

Request a sample of the report: http://www.orbisresearch.com/contacts/request-sample/184634

Technologies Covered:
Tumor Cell Enrichment
Filtration
Centrifugation
Immunological and Immunomagnetic
Tumor Cell Detection
Molecular
Optical

Applications Covered:
Breast Cancer
Colorectal Cancer
Prostate Cancer
Other Applications

Regions Covered:
North America
US
Canada
Mexico
Europe
Germany
France
Italy
UK
Spain
Rest of Europe
Asia Pacific
Japan
China
India
Australia
New Zealand
Rest of Asia Pacific
Rest of the World
Middle East
Brazil
Argentina
South Africa
Egypt

What our report offers:
– Market share assessments for the regional and country level segments
– Market share analysis of the top industry players
– Strategic recommendations for the new entrants
– Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
– Strategic recommendations in key business segments based on the market estimations
– Competitive landscaping mapping the key common trends
– Company profiling with detailed strategies, financials, and recent developments
– Supply chain trends mapping the latest technological advancements

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Information:

Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Email: sales@orbisresearch.com

Global Breast Pump Market to Reach $1,389.2 Million by 2022 – Orbis Research

According to Stratistics MRC, the Global Breast Pump Market is accounted for $830.4 million in 2015 and is expected to reach $1,389.2 million by 2022 growing at a CAGR of 7.6% from 2015 to 2022. Rising demand for healthcare fraternity is the primary factor fuelling the market growth. Furthermore, Technological advancement in breast pumps, growing healthcare expenditure and better reimbursement policies are the major drivers favoring the market growth. However, high cost of breast pumps, contamination associated with the breast pumps and strenuous maintenance of the devices are hampering the market growth. The recent trends in Breast Pump market are hand free pumps which are expected to fuel the market demand.

Browse the report: http://www.orbisresearch.com/reports/index/breast-pump-global-market-outlook-2015-2022

Closed system market segment is expected to account for 80% of market share. Electric breast pumps for hospital use dominated the overall market with nearly 91% of market share. North America dominates the global breast pumps market followed by Europe, owing to growing women employment rates, rising population, and technological advancements. Asia-Pacific is the fastest growing market for global breast pumps due to developing healthcare expenditure, growing disposable income, and government initiatives in declining breast pump tax in the market.

Some of the key players in the market include Ameda AG, Bailey Medical Engineering, Buettner-Frank GmbH, Energizer Holdings, Inc., Guangzhou Happy Baby Products Ltd, Hygeia Medical Group, Lansinoh Laboratories, Linco Baby Merchandise Work’s Co., Medela AG, NUK USA LLC, Philips AVENT, Pigeon Corporation, Royal Philips Electronics NV, Whittlestone, Inc. and Albert International.

Request a sample of the report: http://www.orbisresearch.com/contacts/request-sample/184633

Technologies Covered:
Battery-powered pumps
Manual Pumps
Electric pumps

Products Covered:
Closed system
Open system

Applications Covered:
Healthcare (Hospital Grade) Use
Personal Use

Regions Covered:
North America
US
Canada
Mexico
Europe
Germany
France
Italy
UK
Spain
Rest of Europe
Asia Pacific
Japan
China
India
Australia
New Zealand
Rest of Asia Pacific
Rest of the World
Middle East
Brazil
Argentina
South Africa
Egypt

What our report offers:
– Market share assessments for the regional and country level segments
– Market share analysis of the top industry players
– Strategic recommendations for the new entrants
– Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
– Strategic recommendations in key business segments based on the market estimations
– Competitive landscaping mapping the key common trends
– Company profiling with detailed strategies, financials, and recent developments
– Supply chain trends mapping the latest technological advancements

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Information:

Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Email: sales@orbisresearch.com

Global Neurovascular Devices Market Risk Analysis, Competitor Analysis, Choice Modelling, Trends and Forecast by 2022

According to Stratistics MRC, the Global Neurovascular Devices Market is poised to grow at a CAGR of 8.1% over the forecast period 2015 to 2022. Increasing ageing population, rising market demand for effective neurovascular devices are some of the key factors driving the market growth. In progress healthcare reforms in the U.S. is restraining the growth of neurovascular devices market. One of the key challenges in neurovascular devices market is the stringent regulatory policies. In 2015, aneurysm coiling and embolization devices segment is estimated for the largest share.

Browse the report: http://www.orbisresearch.com/reports/index/neurovascular-devices-global-market-outlook-2015-2022

Asia Pacific is expected to grow at the highest CAGR, due to increasing awareness among neurologists related to benefits of interventional neurology devices and falling prices of neurovascular devices in Asia Pacific.

Some of the key players in the market include Abbott Laboratories, Johnson & Johnson, Medikit Co., Ltd, Medtronic, plc, Merit Medical Systems, Inc., Microport Scientific Corporation, Penumbra, Inc., Terumo Corporation, Stryker Corporation, W. L. Gore & Associates, Inc., Cardiatis, S.A., ITGI Medical Ltd., Bayer AG, Covidien (ev3), Boston Scientific Corporation and Chestnut Medical Technologies.

Request a sample of the report: http://www.orbisresearch.com/contacts/request-sample/184630

End User Covered:
Ambulatory Surgical Centers
Hospitals
Clinics

Products Covered:
Cerebral Balloon Angioplasty & Stenting Systems
Embolic Protection Systems
Carotid Artery Stents
Neurothrombectomy Devices
Snares
Clot Retrievers
Suction and Aspiration Devices
Aneurysm Coiling & Embolization Devices
Liquid Embolic Agents
Embolic Coils
Flow Diversion Devices
Support Devices
Micrguide wires
Micrcatheters

Technology Covered:
Neurothrombectomy
Supporting Technologies
Embolization and Coiling
Carotid Artery Angioplasty and Stenting

Regions Covered:
North America
US
Canada
Mexico
Europe
Germany
France
Italy
UK
Spain
Rest of Europe
Asia Pacific
Japan
China
India
Australia
New Zealand
Rest of Asia Pacific
Rest of the World
Middle East
Brazil
Argentina
South Africa
Egypt

What our report offers:
– Market share assessments for the regional and country level segments
– Market share analysis of the top industry players
– Strategic recommendations for the new entrants
– Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
– Strategic recommendations in key business segments based on the market estimations
– Competitive landscaping mapping the key common trends
– Company profiling with detailed strategies, financials, and recent developments
– Supply chain trends mapping the latest technological advancements

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Information:

Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Email: sales@orbisresearch.com

Biodetectors and Accessories Global Market to Reach $15.2 Billion by 2022

The Global Biodetectors and Accessories Market is expected to reach $15.2 billion by 2022. Continuous decline of environmental surroundings as a result of rising pollution and growing demand for technologically highly developed instruments are the factors driving the market growth. High cost of devices is the factor restraining the market. North America held the major revenue share of overall market followed by Europe. The Asia Pacific region is expected to witness profitable growth opportunities in future due to rising outsourcing actions and improving healthcare infrastructure.

Browse the report: http://www.orbisresearch.com/reports/index/biodetectors-and-accessories-global-market-outlook-2015-2022

Instruments held the major share of the products segment and accounted for more than 32% due to integration of broad variety of applications. Clinical application dominated the application segment and accounted for about 40% of overall industry. Defense segment is likely to show fastest growth due to increasing number of threats driving the demand for biodetectors and accessories. Point of care testing dominated the end-user segment as a result of increasing penetration of devices in medical analytics and rapid diagnosis of heart diseases through discovery of biomarkers.

Some of the key players in the market include Shimadzu Corporation, Agilent Technologies, Smith Detection, MSA the Safety Company, Bio Rad Laboratories, Research International, BioDetection Instruments, Inc., Response BioMedical, Thermo Fisher Scientific, Bertin Technologies, PositiveID Corporation, NetBio, Inc., BBI Detection, Physical Sciences, Inc. and MBio Diagnostics, Inc.

Request a sample of the report: http://www.orbisresearch.com/contacts/request-sample/184626

Applications Covered:
Food & Environmental
Clinical
Defense

Products Covered:
Reagents & Media
Instruments
Accessories & Consumables

End Users Covered:
Diagnostics
Food
Research Laboratories
Point of Care Testing
Others
Environmental Industry
Defense

Regions Covered:
North America
US
Canada
Mexico
Europe
Germany
France
Italy
UK
Spain
Rest of Europe
Asia Pacific
Japan
China
India
Australia
New Zealand
Rest of Asia Pacific
Rest of the World
Middle East
Brazil
Argentina
South Africa
Egypt

What our report offers:
– Market share assessments for the regional and country level segments
– Market share analysis of the top industry players
– Strategic recommendations for the new entrants
– Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
– Strategic recommendations in key business segments based on the market estimations
– Competitive landscaping mapping the key common trends
– Company profiling with detailed strategies, financials, and recent developments
– Supply chain trends mapping the latest technological advancements

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Information:

Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Email: sales@orbisresearch.com